+ All Categories
Home > Documents > interstitiallungdisease-100122140036-phpapp01.ppt

interstitiallungdisease-100122140036-phpapp01.ppt

Date post: 02-Jun-2018
Category:
Upload: andres-menendez-rojas
View: 219 times
Download: 0 times
Share this document with a friend

of 36

Transcript
  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    1/36

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    2/36

    52 / F comes with complains ofCough with minimum mucoid expectoration 6-7 yrsDOE gradually progressive 3-4 yrsHOPI :-No H/o fever,No h/o pul TBNo h/o palpitations,PND , orthopnea,

    O/e:Tachypnoea and Bibasilar Inspiratory CracklesClubbing +nt.

    X ray was advised and it showed some B/L interstitialopacities

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    3/36

    How to suspect an INTERSTITIAL LUNG

    DISEASE. How to find its Cause How to differentiate using imaging and

    simpler procedure rather than doing a TBLB orOpen lung biopsy

    Which ILDs have good prognosis

    Whats the Supportive Treatment

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    4/36

    COMMON FEATURES OF ILD History :Chronic non productive cough with progressive exertional

    dysnoea. Examination :-Tachypnoea +/- Respiratory distressCynosis and clubbingBibasilar Inspiratory cracklesf/s/o pul HT and cor pulmonale IMAGING : - Interstitial pattern PFT:- Restrictive pattern DLco :- Reduced

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    5/36

    IDIOPATHICINTERSTITIALPNEUMONIA

    NS- UIP

    AIPCOP/BOOPDIPRB-ILD

    IPF

    Smoking related

    Due to KNOWNCAUSE

    EnvironmentalPneumoconiosis

    HPGases n fumesIatrogenicDrugsIrradiationMicrobes

    DCTD

    GRANULOMATOSISsarcoidosis

    Langerhans cellhistiocytosis

    Wegener'sgranulomatosis,

    Churg-Strauss

    Syndrome

    RARE ILD

    alv.proteinosisalv.microlithiasisamyloidosiseosinophilic pneumonialymphangioleiomyomatosisidiopathic pulmonaryhemosiderosis

    INTERSTITIAL LUNG DISEASE

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    6/36

    INTERSTITIAL LUNG DISEASEOn basis ofPFT and DLco

    Is it due toenvironmental /iatrogenic factors

    Avoid those factors andmonitor response

    Is it due to asystemic diseaseOr microbialorigin

    No response

    SerologySkin BiopsySputum c/s

    HRCT and BAL

    TBLB orOpen LungBiopsy

    CanDiagnosis andprognosis beestablished

    HISTORY

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    7/36

    ILD with obstructive component

    Sarcoidosis Hypersensitivity pneumonitis Langerhans cell granulomatosis Lymphangioleiomyomatosis

    Tuberous sclerosis Combined COPD and ILD

    RELATIVE CONTRA INDICATIONS FOR A LUNG BIOPSY

    Honey combing or evidence of end stage diseaseSevere pulmonary dysfunctionMajor operative risk

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    8/36

    Environment Dependent ILD

    MINING INDUSTRY:

    Coal workers pneumoconiosis

    Silicosis Asbestosis

    HYPERSENSITVE PNEUMONITIS

    GAS or FUME Exposure

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    9/36

    oal minerspneumoconioisis

    Rounded opacities between 1 and 5 mm(upper and middle zones)

    small irregular and linear opacities

    Progressive massive fibrosisalmost always starts in an upper zone

    Calcification is not a feature

    Cavitation of PMF can occur

    Caplan's syndrome is the name given to the combinationof rheumatoid disease and several round nodules (usually1 to 5 cm in diameter) in the lungs of a coal miner.

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    10/36

    SILI OSISClues to diagnosisMicronodular pattern

    Simple silicosis :Upper lobesSmall multiple nodulesEgg shell calcification

    Complicated :>1 cm nodules

    Acute silicosis :

    small nodular pattern with ground glassappearance ( crazy paving )

    PMF : nodules coalesce to large masses

    BAL : dust particles on polarised light

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    11/36

    Clues to diagnosis

    X Ray:reticular interstitial patternpleural plaques ( lower lung field , cardiacborder and diaphragm )Irrregular linear opacities first noted in

    lower lung fields.

    HRCT :Distinct subpleural curvilinear opacities 5-10 mm length parallel to pleural surface

    BAL: Asbestos bodies

    ASBESTOSIS

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    12/36

    HISTORY of exposure to an offending antigenTemporal association +nt

    characteristic signs and symptomsPFT and Imaging ( ILD pattern )presence of granulomatous inflammationAbsence of eiosinophiliaBAL : marked lymphocytosis > 50%

    HYPERSENSITIVITY PNEUMONITIS

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    13/36

    Suspect a CTD if

    Musculosketetal painWeaknessFatigueJoint pains and swellingPhotosensitivity

    Raynauds phenomenonPleuritisDry eyes or mouth

    INTERSTITIAL LUNG DISEASE in CTD

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    14/36

    SYSTEMIC SLEROSISLung manifestation may be first SS sign in 55%Lung involvement +nt in 90 % ( detected by PFT )

    Vascular Involvement is not vasculitis but intimal hypertrophy (CREST )

    RAMC lung manifestation : Fibrosing alveolitisMale predominancePleural diseasePleuro pulmonary nodules (may cavitate to produce pneumothorax )Caplan Syndrome

    SLEILD is rare . Pleural involvement is common

    POLYMYOSITIS / DERMATOMYOSITISILD in 10 %a combination of patchy consolidation with a peripheral reticularpattern being highly characteristic.

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    15/36

    HRCT in RA

    bibasilar peripheral reticular pattern,intralobular interstitial thickeningdistortion of the lung parenchymaBilateral is present, predominantly on theleft side

    bibasilar peripheral reticular pattern,

    pleural effusion

    thickening of the interlobular septa,

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    16/36

    VasculiticDisorders Lung Involvement ANCA Interstial Patternseen

    Wegenergranulomatosis

    Common c-ANCA >> p-ANCA80 90%

    Diffuse AlveolarHemorrage withnodules ,cavitation

    Microscopicpolyangiitis

    Common Common p-ANCA >c-ANCA80%

    DAH

    Churg-Strausssyndrome

    Common p-ANCA > c-ANCA30 50%

    DAH withtransient infiltates

    Goodpasturesyndrome

    Common p-ANCA10%

    DAH

    Takayasu arteritis Common Negative

    INTERSTITIAL LUNG DISEASE inVASCULITIC DISORDERS

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    17/36

    X ray : consolidation, typically resolving within a matter of days, multipleabcessesHRCT : ground-glass partial alveolar filling.Hb : anaemia ( iron defeciency )BAL :- frank blood-staining in sequential lavage (acute presentation) and numerous macrophages containing iron, identified by Perl's stain

    Dlco :- may be increased in acute conditions but is chronically low

    MC seen is WegenersGranulomatosis

    ILD in VASCULITICDISORDERS

    Suspect if

    Mononeuritis mutiplexRenal involvementSkin lesionshaemoptysis

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    18/36

    DRUG and IRRADIATION and GAS

    DRUGSAmiodarone

    Bleomycin

    BusulphanCarmustine

    ChlorambucilCyclophosphamide

    Cytosine arabinoside

    Lomustine .)

    RADIATION

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    19/36

    IDIOPATHICINTERSTITIALPNEUMONIA

    NS- UIP

    AIPCOP/BOOPDIPRB-ILD

    IPF

    Smoking related

    Due to KNOWNCAUSE

    EnvironmentalPneumoconiosisHPGases n fumesIatrogenicDrugsIrradiationMicrobesDCTD

    GRANULOMATOSISsarcoidosis

    Langerhans cellhistiocytosis

    Wegener'sgranulomatosis,

    Churg-StraussSyndrome

    RARE ILD

    alv.proteinosisalv.microlithiasisamyloidosiseosinophilic pneumonialymphangioleiomyomatosisidiopathic pulmonaryhemosiderosis

    INTERSTITIAL LUNG DISEASE

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    20/36

    UIP or IPF MC of all chronic ILD Typical c/f presentation Median survival approximately 3

    years, depending on stage atpresentation.

    B/L Reticular bibasilar and subpleuralopacities. minimal ground-glass andvariable honeycomb change.

    Type I pneumocytes are lost, and thereis proliferation of alveolar type II cells.

    "Fibroblast foci" of activelyproliferating fibroblasts andmyofibroblasts.

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    21/36

    Disease AgeM:F

    C/F Imaging Prognosis REMARKS

    Respiratorybronchiolitis-associatedinterstitiallung disease

    younger Heavysmokerswithsimilarcomplains

    Like UIP withAirtrappingEmphysematous change

    survivalgreaterthan 10years

    Spontaneousremission20%.

    ILD withObstructivpattern

    Acuteinterstitial

    pneumonitisHamman-Richsyndrome.

    young Apparentlynormal

    indistinguishable fromthat ofidiopathicARDS

    ARDS

    Diffuse b/lairspaceconsolidation with areasof ground-glass

    attenuation

    POOR Mostsevere

    formof ILDPneumonia

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    22/36

    Disease AgeM:F

    C/F Imaging Prognosis REMARKS

    Nonspecificinterstitial

    pneumonitis(NSIP)

    40-50 May beindistinguishable

    from UIP

    LikeBut uniform in

    time, suggestingresponse tosingle injury UIPHoneycombing israre.

    Prognosisgood but

    depends onthe extentof fibrosis atdiagnosisgreater

    than 10years.

    ButSurgical

    Biopsy isneeded toconfirm.

    Cryptogenicorganizingpneumonitis(bronchiolitis

    obliteransorganizingpneumonia[BOOP])

    50 60 Abrupt onset,frequently weeksto a few monthsfollowing a flu-like

    illness.constitutionalsymptoms arecommon

    Ground glassinfiltratesubpleuralconsolidation

    and bronchialwall thickeningand dilation. Xray interstitialpattern withnodules

    Good Rule outinfectionand treatwith

    steroids

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    23/36

    Acute interstitial pneumonitis

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    24/36

    Nonspecific interstitial pneumonitis(NSIP)

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    25/36

    Cryptogenic organizing pneumonitis (bronchiolitisobliterans organizing pneumonia [BOOP])

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    26/36

    Smoking related ILD

    Respiratory bronchiolitis- associatedinterstitial lung disease

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    27/36

    IDIOPATHICINTERSTITIALPNEUMONIA

    NS- UIP

    AIPCOP/BOOPDIPRB-ILD

    IPF

    Smoking related

    Due to KNOWNCAUSE

    EnvironmentalPneumoconiosisHPGases n fumesIatrogenicDrugsIrradiationMicrobesDCTD

    GRANULOMATOSISsarcoidosis

    Langerhans cellhistiocytosis

    Wegener'sgranulomatosis,

    Churg-StraussSyndrome

    RARE ILD

    alv.proteinosisalv.microlithiasisamyloidosiseosinophilic pneumonialymphangioleiomyomatosisidiopathic pulmonary

    hemosiderosis

    INTERSTITIAL LUNG DISEASE

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    28/36

    Sarcoidosis

    Incidental X-ray (20-30 %) Cough , chest discomfort ( upto 50 60 % ) Skin lesions ( 20 -25 % )

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    29/36

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    30/36

    SARCOIDOSIS ctd.

    BAL :- lymphocytosis

    CD4 : CD8 > 3.5 is most specificPFT :- Restrictive pattern

    But Obstructive component present in manyBiopsy :- non caseating granulomas

    lymphocytosis

    Sr. ACE levels:-Hyper calciuria or Hypercalcemia

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    31/36

    RARE ILD

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    32/36

    Primary Alveolar Microlithiasis

    perilobular and bronchovasculardistribution of microliths and subpleuralconsolidation with calcifications in

    the right lung

    SAND STORM appearance

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    33/36

    Pulmonary Alveolar Proteinosis

    diffuse reticulo-alveolar infiltratesBAT WING distribution

    BAL:- milky effulent foamymacrophages with lipoproteinous

    intraalveolar material

    thickened interlobular septa

    crazy paving ground glassfashion, sharply demarked fromnormal lung creating ageographic pattern.

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    34/36

    TREATMENT

    Removal of offending agent if noted Aggressive suppression on inflammatory response Supportive management ( O 2 or ) Treatment of Right heart Failure

    Treatment of Infections Combined effort from family , doctors , physioherapists.

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    35/36

    CYCLOPHOSPHAMIDE or AZATHIOPRINE

    IPF Other ILD as 2 nd line drugs

    1-2 mg / kg /day with or without steroids

    STEROIDS

    BOOP

    CTD ILDEiosinophilic pneumoniaInorganic Dust ILDVasculitic ILDOrganic Dust

    Dose :-0.5 1 mg / kg prednisone for 4 12weeks and then gradual tapering of thedose with repeated monitoring for flareup activity

  • 8/11/2019 interstitiallungdisease-100122140036-phpapp01.ppt

    36/36

    References:

    Harrisons 16/e Atlas Of ILD by OP SharmaOxfords Text book of Medicine 4/e


Recommended